- Home
- TOVX vs GXAI Comparison
TOVX vs GXAI Comparison
Compare TOVX & GXAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | TOVX | GXAI |
|---|---|---|
| Founded | 2001 | 2021 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.1M | 9.1M |
| IPO Year | 2012 | 2022 |
Fundamental Metrics
Financial Performance| Metric | TOVX | GXAI |
|---|---|---|
| Price | $0.25 | $0.75 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $1.00 | N/A |
| AVG Volume (30 Days) | 496.8K | ★ 2.9M |
| Earning Date | 05-13-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 89.07 | 71.35 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $1,933,030.00 |
| Revenue This Year | N/A | $271.23 |
| Revenue Next Year | N/A | $36.32 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 47901.74 |
| 52 Week Low | $0.16 | $0.73 |
| 52 Week High | $0.86 | $2.63 |
Technical Indicators
Market Signals| Indicator | TOVX | GXAI |
|---|---|---|
| Relative Strength Index (RSI) | 55.94 | 40.94 |
| Support Level | $0.22 | $0.75 |
| Resistance Level | $0.26 | $1.30 |
| Average True Range (ATR) | 0.01 | 0.04 |
| MACD | 0.00 | -0.00 |
| Stochastic Oscillator | 63.40 | 7.00 |
Price Performance
Historical ComparisonAbout TOVX Theriva Biologics Inc.
Theriva Biologics Inc is a clinical-stage pharmaceutical company developing a novel oncolytic adenovirus (OV) platform to address devastating cancers with high unmet needs. It is a clinical-stage program VCN-01, designed to break down the tumor stroma, and its preclinical-stage program VCN-11 leverages its proprietary Albumin Shield Technology to protect systemically administered oncolytic viruses from the host immune system. Product Candidates includes SYN-004 (ribaxamase) and SYN-020.
About GXAI Gaxos.ai Inc.
Gaxos.AI Inc is a technology company focused on reshaping the way people interact with artificial intelligence across everyday life and high-impact industries. It is engaged in building a portfolio of AI-powered solutions designed to make advanced technology more practical, accessible, and transformative. The company's portfolio spans defense, health and wellness, entertainment, and productivity - bringing intelligent tools to markets where innovation can drive meaningful real-world outcomes. It operates as a single operating segment technology-based company that is developing applications aimed at redefining the way it utilizes artificial intelligence (AI) to optimize the user experience.